1. Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review

   • María Patricia Hernández-Mitre
   • Steven Y. C. Tong
   • Jason A. Roberts

   Review Article Open access 30 August 2022 Pages: 1331 - 1343

   

2. Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review

   • Kevin Lin
   • Vivien F. S. Cao
   • Karen Dahri

   Systematic Review 30 August 2022 Pages: 1345 - 1363

   

3. Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs

   • Sarah Alrubia
   • Jialin Mao
   • Amin Rostami-Hodjegan

   Systematic Review Open access 03 September 2022 Pages: 1365 - 1392

   

4. Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases

   • Ying Fei Li
   • Francois Pierre Combes
   • Yu-Yun Ho

   Original Research Article 28 June 2022 Pages: 1393 - 1403

   

5. Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment

   • Vidya Perera
   • Grigor Abelian
   • Bindu Murthy

   Original Research Article Open access 30 July 2022 Pages: 1405 - 1416

   

6. Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers

   • Ariel Topletz-Erickson
   • Anthony Lee
   • Christopher J. Endres

   Original Research Article Open access 06 August 2022 Pages: 1417 - 1426

   

7. Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling

   • Shixing Zhu
   • Jiayuan Zhang
   • Sherwin K. B. Sy

   Original Research Article 10 August 2022 Pages: 1427 - 1441

   

8. Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues

   • Romain Garreau
   • Damien Montange
   • Sylvain Goutelle

   Original Research Article 16 August 2022 Pages: 1443 - 1456

   

9. Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis

   • James D. Chalmers
   • Helen Usansky
   • Kevin C. Mange

   Original Research Article Open access 25 July 2022 Pages: 1457 - 1469

   

10. Influence of Darolutamide on Cabazitaxel Systemic Exposure

    • Stefan A. J. Buck
    • Niels A. D. Guchelaar
    • Ron H. J. Mathijssen

    Research Letter 27 July 2022 Pages: 1471 - 1473

    

11. Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases

    • Ying Fei Li
    • Francois Pierre Combes
    • Yu-Yun Ho

    Correction 17 August 2022 Pages: 1475 - 1476